Podbielski F J, Maniar H S, Rodriguez H E, Hernan M J, Vigneswaran W T
The University of Illinois at Chicago, Division of Cardiothoracic Surgery, USA.
JSLS. 2000 Oct-Dec;4(4):287-90.
The optimal treatment of empyema thoracis has been widely debated. Proponents of pleural drainage alone, drainage plus fibrinolytic therapy, video-assisted thoracoscopic surgical (VATS) debridement, and open thoracotomy each champion the efficacy of their approach.
This study examines treatment of complex empyema thoracis between June 1, 1994, and April 30, 1997. Twenty-one men and 9 women underwent 30 drainage/decortication procedures (14 open thoracotomies and 16 VATS) in treatment of their disease. Effusion etiology was distributed as follows: infectious-14; neoplastic-associated-7; traumatic-3; other-6.
The mean preoperative hospital stay was 14 +/- 8.8 days, (11.4 +/- 6.5 days for VATS vs 16.8 +/- 10.2 days for thoracotomy). Hospital stay from operation to discharge for thoracotomy patients was 10.0 -/+ 7.2 days (median 8.5 days) and for VATS patients 17.6 -/+ 16.8 days (median 11 days). These differences were not statistically significant. Duration of postoperative thoracostomy tube drainage was 8.3 -/+ 4.6 days for thoracotomy patients and 4.7 -/+ 2.8 days in the VATS group (p = 0.01). Operative time for the thoracotomy group was 125.0 -/+ 71.7 minutes, while the VATS group time was only 76.2 -/+ 30.7 minutes. Estimated blood loss for the thoracotomy group was 313.9 -/+ 254.0 milliliters and for the VATS group 131.6 -/+ 77.3 milliliters. Three of the 30 patients (10.0%) required prolonged ventilator support (>24 hours). Morbidity included one diaphragmatic laceration (VATS group) and one thoracic duct laceration (thoracotomy). Two VATS procedures (6.7%) required conversion to open thoracotomy for thorough decortication.
The surgical approach to empyema thoracis is evolving. In the absence of comorbid factors, the significantly lower requirement for chest tube drainage time in the VATS patients suggests that this modality is an attractive alternative to thoracotomy in the treatment of complex empyema thoracis.
脓胸的最佳治疗方法一直存在广泛争议。仅支持胸腔引流、引流加纤维蛋白溶解疗法、电视辅助胸腔镜手术(VATS)清创术和开胸手术的各方都各自宣扬其方法的有效性。
本研究调查了1994年6月1日至1997年4月30日期间复杂脓胸的治疗情况。21名男性和9名女性接受了30次引流/剥脱手术(14次开胸手术和16次VATS手术)来治疗他们的疾病。积液病因分布如下:感染性-14例;肿瘤相关性-7例;创伤性-3例;其他-6例。
术前平均住院时间为14±8.8天(VATS组为11.4±6.5天,开胸手术组为16.8±10.2天)。开胸手术患者从手术到出院的住院时间为10.0±7.2天(中位数8.5天),VATS患者为17.6±16.8天(中位数11天)。这些差异无统计学意义。开胸手术患者术后胸腔闭式引流管引流时间为8.3±4.6天,VATS组为4.7±2.8天(p = 0.01)。开胸手术组的手术时间为125.0±71.7分钟,而VATS组仅为76.2±30.7分钟。开胸手术组的估计失血量为313.9±254.0毫升,VATS组为131.6±77.3毫升。30例患者中有3例(10.0%)需要延长呼吸机支持(>24小时)。并发症包括1例膈肌撕裂(VATS组)和1例胸导管撕裂(开胸手术组)。2例VATS手术(6.7%)需要转为开胸手术以进行彻底剥脱。
脓胸的手术治疗方法正在不断发展。在没有合并症的情况下,VATS患者对胸管引流时间的要求显著更低,这表明在治疗复杂脓胸时,这种方式是开胸手术的一种有吸引力的替代方法。